PMC:7243768 / 33275-36272 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1273","span":{"begin":5,"end":15},"obj":"Species"},{"id":"1300","span":{"begin":541,"end":548},"obj":"Gene"},{"id":"1301","span":{"begin":364,"end":371},"obj":"Gene"},{"id":"1302","span":{"begin":62,"end":70},"obj":"Species"},{"id":"1303","span":{"begin":167,"end":175},"obj":"Species"},{"id":"1304","span":{"begin":276,"end":284},"obj":"Species"},{"id":"1305","span":{"begin":490,"end":498},"obj":"Species"},{"id":"1306","span":{"begin":611,"end":619},"obj":"Species"},{"id":"1307","span":{"begin":743,"end":751},"obj":"Species"},{"id":"1308","span":{"begin":860,"end":868},"obj":"Species"},{"id":"1309","span":{"begin":900,"end":908},"obj":"Species"},{"id":"1310","span":{"begin":958,"end":966},"obj":"Species"},{"id":"1311","span":{"begin":105,"end":113},"obj":"Disease"},{"id":"1312","span":{"begin":122,"end":141},"obj":"Disease"},{"id":"1313","span":{"begin":297,"end":305},"obj":"Disease"},{"id":"1314","span":{"begin":316,"end":327},"obj":"Disease"},{"id":"1315","span":{"begin":421,"end":430},"obj":"Disease"},{"id":"1316","span":{"begin":510,"end":521},"obj":"Disease"},{"id":"1317","span":{"begin":581,"end":594},"obj":"Disease"},{"id":"1318","span":{"begin":630,"end":641},"obj":"Disease"},{"id":"1319","span":{"begin":646,"end":655},"obj":"Disease"},{"id":"1320","span":{"begin":772,"end":780},"obj":"Disease"},{"id":"1321","span":{"begin":884,"end":899},"obj":"Disease"},{"id":"1322","span":{"begin":940,"end":948},"obj":"Disease"},{"id":"1323","span":{"begin":1008,"end":1017},"obj":"Disease"},{"id":"1324","span":{"begin":1037,"end":1048},"obj":"Disease"},{"id":"1325","span":{"begin":1053,"end":1062},"obj":"Disease"},{"id":"1367","span":{"begin":2104,"end":2122},"obj":"Gene"},{"id":"1368","span":{"begin":2538,"end":2564},"obj":"Gene"},{"id":"1369","span":{"begin":1380,"end":1388},"obj":"Species"},{"id":"1370","span":{"begin":1444,"end":1452},"obj":"Species"},{"id":"1371","span":{"begin":1472,"end":1480},"obj":"Species"},{"id":"1372","span":{"begin":1568,"end":1576},"obj":"Species"},{"id":"1373","span":{"begin":1641,"end":1649},"obj":"Species"},{"id":"1374","span":{"begin":1755,"end":1763},"obj":"Species"},{"id":"1375","span":{"begin":1958,"end":1966},"obj":"Species"},{"id":"1376","span":{"begin":1978,"end":1986},"obj":"Species"},{"id":"1377","span":{"begin":2163,"end":2171},"obj":"Species"},{"id":"1378","span":{"begin":2290,"end":2298},"obj":"Species"},{"id":"1379","span":{"begin":2300,"end":2308},"obj":"Species"},{"id":"1380","span":{"begin":2467,"end":2475},"obj":"Species"},{"id":"1381","span":{"begin":2646,"end":2654},"obj":"Species"},{"id":"1382","span":{"begin":2813,"end":2821},"obj":"Species"},{"id":"1383","span":{"begin":1512,"end":1520},"obj":"Chemical"},{"id":"1384","span":{"begin":1530,"end":1534},"obj":"Chemical"},{"id":"1385","span":{"begin":1535,"end":1543},"obj":"Chemical"},{"id":"1386","span":{"begin":2208,"end":2216},"obj":"Chemical"},{"id":"1387","span":{"begin":2248,"end":2255},"obj":"Chemical"},{"id":"1388","span":{"begin":2335,"end":2343},"obj":"Chemical"},{"id":"1389","span":{"begin":2671,"end":2679},"obj":"Chemical"},{"id":"1390","span":{"begin":1228,"end":1236},"obj":"Disease"},{"id":"1391","span":{"begin":1393,"end":1415},"obj":"Disease"},{"id":"1392","span":{"begin":1609,"end":1620},"obj":"Disease"},{"id":"1393","span":{"begin":1680,"end":1699},"obj":"Disease"},{"id":"1394","span":{"begin":1716,"end":1724},"obj":"Disease"},{"id":"1395","span":{"begin":1725,"end":1734},"obj":"Disease"},{"id":"1396","span":{"begin":1877,"end":1885},"obj":"Disease"},{"id":"1397","span":{"begin":1886,"end":1895},"obj":"Disease"},{"id":"1398","span":{"begin":2006,"end":2009},"obj":"Disease"},{"id":"1399","span":{"begin":2592,"end":2611},"obj":"Disease"},{"id":"1400","span":{"begin":2714,"end":2723},"obj":"Disease"},{"id":"1401","span":{"begin":2794,"end":2809},"obj":"Disease"},{"id":"1402","span":{"begin":2834,"end":2842},"obj":"Disease"},{"id":"1403","span":{"begin":2881,"end":2890},"obj":"Disease"},{"id":"1404","span":{"begin":2925,"end":2947},"obj":"Disease"},{"id":"1405","span":{"begin":2949,"end":2968},"obj":"Disease"},{"id":"1406","span":{"begin":2970,"end":2981},"obj":"Disease"},{"id":"1407","span":{"begin":2987,"end":2996},"obj":"Disease"}],"attributes":[{"id":"A1273","pred":"tao:has_database_id","subj":"1273","obj":"Tax:2697049"},{"id":"A1300","pred":"tao:has_database_id","subj":"1300","obj":"Gene:213"},{"id":"A1301","pred":"tao:has_database_id","subj":"1301","obj":"Gene:213"},{"id":"A1302","pred":"tao:has_database_id","subj":"1302","obj":"Tax:9606"},{"id":"A1303","pred":"tao:has_database_id","subj":"1303","obj":"Tax:9606"},{"id":"A1304","pred":"tao:has_database_id","subj":"1304","obj":"Tax:9606"},{"id":"A1305","pred":"tao:has_database_id","subj":"1305","obj":"Tax:9606"},{"id":"A1306","pred":"tao:has_database_id","subj":"1306","obj":"Tax:9606"},{"id":"A1307","pred":"tao:has_database_id","subj":"1307","obj":"Tax:9606"},{"id":"A1308","pred":"tao:has_database_id","subj":"1308","obj":"Tax:9606"},{"id":"A1309","pred":"tao:has_database_id","subj":"1309","obj":"Tax:9606"},{"id":"A1310","pred":"tao:has_database_id","subj":"1310","obj":"Tax:9606"},{"id":"A1311","pred":"tao:has_database_id","subj":"1311","obj":"MESH:C000657245"},{"id":"A1312","pred":"tao:has_database_id","subj":"1312","obj":"MESH:D058186"},{"id":"A1313","pred":"tao:has_database_id","subj":"1313","obj":"MESH:C000657245"},{"id":"A1314","pred":"tao:has_database_id","subj":"1314","obj":"MESH:D011507"},{"id":"A1315","pred":"tao:has_database_id","subj":"1315","obj":"MESH:D007239"},{"id":"A1316","pred":"tao:has_database_id","subj":"1316","obj":"MESH:D011507"},{"id":"A1317","pred":"tao:has_database_id","subj":"1317","obj":"MESH:D007674"},{"id":"A1318","pred":"tao:has_database_id","subj":"1318","obj":"MESH:D011507"},{"id":"A1319","pred":"tao:has_database_id","subj":"1319","obj":"MESH:D006417"},{"id":"A1320","pred":"tao:has_database_id","subj":"1320","obj":"MESH:C000657245"},{"id":"A1321","pred":"tao:has_database_id","subj":"1321","obj":"MESH:D012141"},{"id":"A1322","pred":"tao:has_database_id","subj":"1322","obj":"MESH:C000657245"},{"id":"A1323","pred":"tao:has_database_id","subj":"1323","obj":"MESH:D006417"},{"id":"A1324","pred":"tao:has_database_id","subj":"1324","obj":"MESH:D011507"},{"id":"A1325","pred":"tao:has_database_id","subj":"1325","obj":"MESH:D006417"},{"id":"A1367","pred":"tao:has_database_id","subj":"1367","obj":"Gene:1401"},{"id":"A1368","pred":"tao:has_database_id","subj":"1368","obj":"Gene:26503"},{"id":"A1369","pred":"tao:has_database_id","subj":"1369","obj":"Tax:9606"},{"id":"A1370","pred":"tao:has_database_id","subj":"1370","obj":"Tax:9606"},{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"Tax:9606"},{"id":"A1372","pred":"tao:has_database_id","subj":"1372","obj":"Tax:9606"},{"id":"A1373","pred":"tao:has_database_id","subj":"1373","obj":"Tax:9606"},{"id":"A1374","pred":"tao:has_database_id","subj":"1374","obj":"Tax:9606"},{"id":"A1375","pred":"tao:has_database_id","subj":"1375","obj":"Tax:9606"},{"id":"A1376","pred":"tao:has_database_id","subj":"1376","obj":"Tax:9606"},{"id":"A1377","pred":"tao:has_database_id","subj":"1377","obj":"Tax:9606"},{"id":"A1378","pred":"tao:has_database_id","subj":"1378","obj":"Tax:9606"},{"id":"A1379","pred":"tao:has_database_id","subj":"1379","obj":"Tax:9606"},{"id":"A1380","pred":"tao:has_database_id","subj":"1380","obj":"Tax:9606"},{"id":"A1381","pred":"tao:has_database_id","subj":"1381","obj":"Tax:9606"},{"id":"A1382","pred":"tao:has_database_id","subj":"1382","obj":"Tax:9606"},{"id":"A1383","pred":"tao:has_database_id","subj":"1383","obj":"MESH:D003401"},{"id":"A1384","pred":"tao:has_database_id","subj":"1384","obj":"MESH:D014508"},{"id":"A1385","pred":"tao:has_database_id","subj":"1385","obj":"MESH:D009584"},{"id":"A1386","pred":"tao:has_database_id","subj":"1386","obj":"MESH:D003401"},{"id":"A1387","pred":"tao:has_database_id","subj":"1387","obj":"MESH:D007785"},{"id":"A1388","pred":"tao:has_database_id","subj":"1388","obj":"MESH:D003401"},{"id":"A1389","pred":"tao:has_database_id","subj":"1389","obj":"MESH:D003401"},{"id":"A1390","pred":"tao:has_database_id","subj":"1390","obj":"MESH:C000657245"},{"id":"A1391","pred":"tao:has_database_id","subj":"1391","obj":"MESH:D051436"},{"id":"A1392","pred":"tao:has_database_id","subj":"1392","obj":"MESH:D000419"},{"id":"A1393","pred":"tao:has_database_id","subj":"1393","obj":"MESH:D058186"},{"id":"A1394","pred":"tao:has_database_id","subj":"1394","obj":"MESH:C000657245"},{"id":"A1395","pred":"tao:has_database_id","subj":"1395","obj":"MESH:D007239"},{"id":"A1396","pred":"tao:has_database_id","subj":"1396","obj":"MESH:C000657245"},{"id":"A1397","pred":"tao:has_database_id","subj":"1397","obj":"MESH:D007239"},{"id":"A1398","pred":"tao:has_database_id","subj":"1398","obj":"MESH:D012080"},{"id":"A1399","pred":"tao:has_database_id","subj":"1399","obj":"MESH:D058186"},{"id":"A1400","pred":"tao:has_database_id","subj":"1400","obj":"MESH:D003643"},{"id":"A1401","pred":"tao:has_database_id","subj":"1401","obj":"MESH:D007674"},{"id":"A1402","pred":"tao:has_database_id","subj":"1402","obj":"MESH:C000657245"},{"id":"A1403","pred":"tao:has_database_id","subj":"1403","obj":"MESH:D003643"},{"id":"A1404","pred":"tao:has_database_id","subj":"1404","obj":"MESH:D051436"},{"id":"A1405","pred":"tao:has_database_id","subj":"1405","obj":"MESH:D058186"},{"id":"A1406","pred":"tao:has_database_id","subj":"1406","obj":"MESH:D011507"},{"id":"A1407","pred":"tao:has_database_id","subj":"1407","obj":"MESH:D006417"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T287","span":{"begin":17,"end":23},"obj":"Body_part"},{"id":"T288","span":{"begin":88,"end":94},"obj":"Body_part"},{"id":"T289","span":{"begin":128,"end":134},"obj":"Body_part"},{"id":"T290","span":{"begin":375,"end":380},"obj":"Body_part"},{"id":"T291","span":{"begin":581,"end":587},"obj":"Body_part"},{"id":"T292","span":{"begin":689,"end":694},"obj":"Body_part"},{"id":"T293","span":{"begin":702,"end":707},"obj":"Body_part"},{"id":"T294","span":{"begin":823,"end":829},"obj":"Body_part"},{"id":"T295","span":{"begin":1077,"end":1083},"obj":"Body_part"},{"id":"T296","span":{"begin":1326,"end":1332},"obj":"Body_part"},{"id":"T297","span":{"begin":1401,"end":1407},"obj":"Body_part"},{"id":"T298","span":{"begin":1524,"end":1529},"obj":"Body_part"},{"id":"T299","span":{"begin":1686,"end":1692},"obj":"Body_part"},{"id":"T300","span":{"begin":2027,"end":2038},"obj":"Body_part"},{"id":"T301","span":{"begin":2115,"end":2122},"obj":"Body_part"},{"id":"T302","span":{"begin":2201,"end":2206},"obj":"Body_part"},{"id":"T303","span":{"begin":2242,"end":2247},"obj":"Body_part"},{"id":"T304","span":{"begin":2329,"end":2334},"obj":"Body_part"},{"id":"T305","span":{"begin":2401,"end":2409},"obj":"Body_part"},{"id":"T306","span":{"begin":2414,"end":2425},"obj":"Body_part"},{"id":"T307","span":{"begin":2445,"end":2455},"obj":"Body_part"},{"id":"T308","span":{"begin":2598,"end":2604},"obj":"Body_part"},{"id":"T309","span":{"begin":2665,"end":2670},"obj":"Body_part"},{"id":"T310","span":{"begin":2794,"end":2800},"obj":"Body_part"},{"id":"T311","span":{"begin":2933,"end":2939},"obj":"Body_part"},{"id":"T312","span":{"begin":2955,"end":2961},"obj":"Body_part"}],"attributes":[{"id":"A287","pred":"fma_id","subj":"T287","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A288","pred":"fma_id","subj":"T288","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A289","pred":"fma_id","subj":"T289","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A290","pred":"fma_id","subj":"T290","obj":"http://purl.org/sig/ont/fma/fma12274"},{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A292","pred":"fma_id","subj":"T292","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A293","pred":"fma_id","subj":"T293","obj":"http://purl.org/sig/ont/fma/fma12274"},{"id":"A294","pred":"fma_id","subj":"T294","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A295","pred":"fma_id","subj":"T295","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A296","pred":"fma_id","subj":"T296","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A297","pred":"fma_id","subj":"T297","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A298","pred":"fma_id","subj":"T298","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A299","pred":"fma_id","subj":"T299","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A300","pred":"fma_id","subj":"T300","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A301","pred":"fma_id","subj":"T301","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A302","pred":"fma_id","subj":"T302","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A303","pred":"fma_id","subj":"T303","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A304","pred":"fma_id","subj":"T304","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A305","pred":"fma_id","subj":"T305","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A306","pred":"fma_id","subj":"T306","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A307","pred":"fma_id","subj":"T307","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A308","pred":"fma_id","subj":"T308","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A309","pred":"fma_id","subj":"T309","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A310","pred":"fma_id","subj":"T310","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A311","pred":"fma_id","subj":"T311","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A312","pred":"fma_id","subj":"T312","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T141","span":{"begin":17,"end":23},"obj":"Body_part"},{"id":"T142","span":{"begin":88,"end":94},"obj":"Body_part"},{"id":"T143","span":{"begin":128,"end":134},"obj":"Body_part"},{"id":"T144","span":{"begin":375,"end":380},"obj":"Body_part"},{"id":"T145","span":{"begin":581,"end":587},"obj":"Body_part"},{"id":"T146","span":{"begin":689,"end":694},"obj":"Body_part"},{"id":"T147","span":{"begin":702,"end":707},"obj":"Body_part"},{"id":"T148","span":{"begin":823,"end":829},"obj":"Body_part"},{"id":"T149","span":{"begin":1077,"end":1083},"obj":"Body_part"},{"id":"T150","span":{"begin":1326,"end":1332},"obj":"Body_part"},{"id":"T151","span":{"begin":1401,"end":1407},"obj":"Body_part"},{"id":"T152","span":{"begin":1524,"end":1529},"obj":"Body_part"},{"id":"T153","span":{"begin":1686,"end":1692},"obj":"Body_part"},{"id":"T154","span":{"begin":2201,"end":2206},"obj":"Body_part"},{"id":"T155","span":{"begin":2242,"end":2247},"obj":"Body_part"},{"id":"T156","span":{"begin":2329,"end":2334},"obj":"Body_part"},{"id":"T157","span":{"begin":2598,"end":2604},"obj":"Body_part"},{"id":"T158","span":{"begin":2665,"end":2670},"obj":"Body_part"},{"id":"T159","span":{"begin":2794,"end":2800},"obj":"Body_part"},{"id":"T160","span":{"begin":2933,"end":2939},"obj":"Body_part"},{"id":"T161","span":{"begin":2955,"end":2961},"obj":"Body_part"}],"attributes":[{"id":"A141","pred":"uberon_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A142","pred":"uberon_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A143","pred":"uberon_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A144","pred":"uberon_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/UBERON_0001088"},{"id":"A145","pred":"uberon_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A146","pred":"uberon_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A147","pred":"uberon_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/UBERON_0001088"},{"id":"A148","pred":"uberon_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A149","pred":"uberon_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A150","pred":"uberon_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A151","pred":"uberon_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A152","pred":"uberon_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A153","pred":"uberon_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A154","pred":"uberon_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A155","pred":"uberon_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A156","pred":"uberon_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A157","pred":"uberon_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A158","pred":"uberon_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A159","pred":"uberon_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A160","pred":"uberon_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A161","pred":"uberon_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T379","span":{"begin":5,"end":13},"obj":"Disease"},{"id":"T380","span":{"begin":5,"end":9},"obj":"Disease"},{"id":"T381","span":{"begin":105,"end":113},"obj":"Disease"},{"id":"T382","span":{"begin":122,"end":141},"obj":"Disease"},{"id":"T383","span":{"begin":135,"end":141},"obj":"Disease"},{"id":"T384","span":{"begin":297,"end":305},"obj":"Disease"},{"id":"T385","span":{"begin":316,"end":327},"obj":"Disease"},{"id":"T386","span":{"begin":421,"end":430},"obj":"Disease"},{"id":"T387","span":{"begin":510,"end":521},"obj":"Disease"},{"id":"T388","span":{"begin":630,"end":641},"obj":"Disease"},{"id":"T389","span":{"begin":772,"end":780},"obj":"Disease"},{"id":"T390","span":{"begin":940,"end":948},"obj":"Disease"},{"id":"T391","span":{"begin":1037,"end":1048},"obj":"Disease"},{"id":"T392","span":{"begin":1228,"end":1236},"obj":"Disease"},{"id":"T393","span":{"begin":1393,"end":1415},"obj":"Disease"},{"id":"T394","span":{"begin":1401,"end":1415},"obj":"Disease"},{"id":"T396","span":{"begin":1417,"end":1420},"obj":"Disease"},{"id":"T397","span":{"begin":1680,"end":1699},"obj":"Disease"},{"id":"T398","span":{"begin":1693,"end":1699},"obj":"Disease"},{"id":"T399","span":{"begin":1701,"end":1704},"obj":"Disease"},{"id":"T400","span":{"begin":1716,"end":1724},"obj":"Disease"},{"id":"T401","span":{"begin":1725,"end":1734},"obj":"Disease"},{"id":"T402","span":{"begin":1877,"end":1885},"obj":"Disease"},{"id":"T403","span":{"begin":1886,"end":1895},"obj":"Disease"},{"id":"T404","span":{"begin":2006,"end":2009},"obj":"Disease"},{"id":"T405","span":{"begin":2592,"end":2611},"obj":"Disease"},{"id":"T406","span":{"begin":2605,"end":2611},"obj":"Disease"},{"id":"T407","span":{"begin":2688,"end":2691},"obj":"Disease"},{"id":"T408","span":{"begin":2794,"end":2809},"obj":"Disease"},{"id":"T410","span":{"begin":2834,"end":2842},"obj":"Disease"},{"id":"T411","span":{"begin":2925,"end":2947},"obj":"Disease"},{"id":"T412","span":{"begin":2933,"end":2947},"obj":"Disease"},{"id":"T414","span":{"begin":2949,"end":2968},"obj":"Disease"},{"id":"T415","span":{"begin":2962,"end":2968},"obj":"Disease"},{"id":"T416","span":{"begin":2970,"end":2981},"obj":"Disease"}],"attributes":[{"id":"A379","pred":"mondo_id","subj":"T379","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A380","pred":"mondo_id","subj":"T380","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A381","pred":"mondo_id","subj":"T381","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A382","pred":"mondo_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A383","pred":"mondo_id","subj":"T383","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A384","pred":"mondo_id","subj":"T384","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A385","pred":"mondo_id","subj":"T385","obj":"http://purl.obolibrary.org/obo/MONDO_0003634"},{"id":"A386","pred":"mondo_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A387","pred":"mondo_id","subj":"T387","obj":"http://purl.obolibrary.org/obo/MONDO_0003634"},{"id":"A388","pred":"mondo_id","subj":"T388","obj":"http://purl.obolibrary.org/obo/MONDO_0003634"},{"id":"A389","pred":"mondo_id","subj":"T389","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A390","pred":"mondo_id","subj":"T390","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A391","pred":"mondo_id","subj":"T391","obj":"http://purl.obolibrary.org/obo/MONDO_0003634"},{"id":"A392","pred":"mondo_id","subj":"T392","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A393","pred":"mondo_id","subj":"T393","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A394","pred":"mondo_id","subj":"T394","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A395","pred":"mondo_id","subj":"T394","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A396","pred":"mondo_id","subj":"T396","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A397","pred":"mondo_id","subj":"T397","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A398","pred":"mondo_id","subj":"T398","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A399","pred":"mondo_id","subj":"T399","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A400","pred":"mondo_id","subj":"T400","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A401","pred":"mondo_id","subj":"T401","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A402","pred":"mondo_id","subj":"T402","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A403","pred":"mondo_id","subj":"T403","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A404","pred":"mondo_id","subj":"T404","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A405","pred":"mondo_id","subj":"T405","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A406","pred":"mondo_id","subj":"T406","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A407","pred":"mondo_id","subj":"T407","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A408","pred":"mondo_id","subj":"T408","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A409","pred":"mondo_id","subj":"T408","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A410","pred":"mondo_id","subj":"T410","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A411","pred":"mondo_id","subj":"T411","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A412","pred":"mondo_id","subj":"T412","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A413","pred":"mondo_id","subj":"T412","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A414","pred":"mondo_id","subj":"T414","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A415","pred":"mondo_id","subj":"T415","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A416","pred":"mondo_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/MONDO_0003634"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T446","span":{"begin":17,"end":23},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T447","span":{"begin":17,"end":23},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T448","span":{"begin":17,"end":23},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T449","span":{"begin":88,"end":94},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T450","span":{"begin":88,"end":94},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T451","span":{"begin":88,"end":94},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T452","span":{"begin":128,"end":134},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T453","span":{"begin":128,"end":134},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T454","span":{"begin":128,"end":134},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T455","span":{"begin":476,"end":478},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T456","span":{"begin":565,"end":566},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T457","span":{"begin":581,"end":587},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T458","span":{"begin":581,"end":587},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T459","span":{"begin":581,"end":587},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T460","span":{"begin":689,"end":694},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T461","span":{"begin":689,"end":694},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T462","span":{"begin":823,"end":829},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T463","span":{"begin":823,"end":829},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T464","span":{"begin":823,"end":829},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T465","span":{"begin":846,"end":848},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T466","span":{"begin":913,"end":914},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T467","span":{"begin":1077,"end":1083},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T468","span":{"begin":1077,"end":1083},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T469","span":{"begin":1077,"end":1083},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T470","span":{"begin":1224,"end":1227},"obj":"http://purl.obolibrary.org/obo/CLO_0001046"},{"id":"T471","span":{"begin":1326,"end":1332},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T472","span":{"begin":1326,"end":1332},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T473","span":{"begin":1326,"end":1332},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T474","span":{"begin":1401,"end":1407},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T475","span":{"begin":1401,"end":1407},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T476","span":{"begin":1401,"end":1407},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T477","span":{"begin":1491,"end":1492},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T478","span":{"begin":1524,"end":1529},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T479","span":{"begin":1524,"end":1529},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T480","span":{"begin":1587,"end":1588},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T481","span":{"begin":1686,"end":1692},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T482","span":{"begin":1686,"end":1692},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T483","span":{"begin":1686,"end":1692},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T484","span":{"begin":2364,"end":2368},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T485","span":{"begin":2364,"end":2368},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T486","span":{"begin":2598,"end":2604},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T487","span":{"begin":2598,"end":2604},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T488","span":{"begin":2598,"end":2604},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T489","span":{"begin":2794,"end":2800},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T490","span":{"begin":2794,"end":2800},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T491","span":{"begin":2794,"end":2800},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T492","span":{"begin":2933,"end":2939},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T493","span":{"begin":2933,"end":2939},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T494","span":{"begin":2933,"end":2939},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T495","span":{"begin":2955,"end":2961},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T496","span":{"begin":2955,"end":2961},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T497","span":{"begin":2955,"end":2961},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T175","span":{"begin":567,"end":576},"obj":"Chemical"},{"id":"T176","span":{"begin":884,"end":890},"obj":"Chemical"},{"id":"T177","span":{"begin":1512,"end":1520},"obj":"Chemical"},{"id":"T179","span":{"begin":1530,"end":1534},"obj":"Chemical"},{"id":"T180","span":{"begin":1535,"end":1543},"obj":"Chemical"},{"id":"T181","span":{"begin":2115,"end":2122},"obj":"Chemical"},{"id":"T182","span":{"begin":2208,"end":2216},"obj":"Chemical"},{"id":"T184","span":{"begin":2248,"end":2255},"obj":"Chemical"},{"id":"T185","span":{"begin":2335,"end":2343},"obj":"Chemical"},{"id":"T187","span":{"begin":2364,"end":2368},"obj":"Chemical"},{"id":"T188","span":{"begin":2538,"end":2547},"obj":"Chemical"},{"id":"T191","span":{"begin":2569,"end":2576},"obj":"Chemical"},{"id":"T192","span":{"begin":2671,"end":2679},"obj":"Chemical"}],"attributes":[{"id":"A175","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_59163"},{"id":"A176","pred":"chebi_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/CHEBI_37409"},{"id":"A177","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"},{"id":"A178","pred":"chebi_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/CHEBI_57947"},{"id":"A179","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_16199"},{"id":"A180","pred":"chebi_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/CHEBI_25555"},{"id":"A181","pred":"chebi_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A182","pred":"chebi_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"},{"id":"A183","pred":"chebi_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/CHEBI_57947"},{"id":"A184","pred":"chebi_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/CHEBI_17716"},{"id":"A185","pred":"chebi_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"},{"id":"A186","pred":"chebi_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/CHEBI_57947"},{"id":"A187","pred":"chebi_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A188","pred":"chebi_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/CHEBI_132943"},{"id":"A189","pred":"chebi_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/CHEBI_29995"},{"id":"A190","pred":"chebi_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/CHEBI_72314"},{"id":"A191","pred":"chebi_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/CHEBI_24996"},{"id":"A192","pred":"chebi_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"},{"id":"A193","pred":"chebi_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/CHEBI_57947"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T223","span":{"begin":0,"end":28},"obj":"Sentence"},{"id":"T224","span":{"begin":29,"end":176},"obj":"Sentence"},{"id":"T225","span":{"begin":177,"end":431},"obj":"Sentence"},{"id":"T226","span":{"begin":432,"end":708},"obj":"Sentence"},{"id":"T227","span":{"begin":709,"end":781},"obj":"Sentence"},{"id":"T228","span":{"begin":782,"end":909},"obj":"Sentence"},{"id":"T229","span":{"begin":910,"end":1063},"obj":"Sentence"},{"id":"T230","span":{"begin":1064,"end":1139},"obj":"Sentence"},{"id":"T231","span":{"begin":1140,"end":1422},"obj":"Sentence"},{"id":"T232","span":{"begin":1423,"end":1628},"obj":"Sentence"},{"id":"T233","span":{"begin":1629,"end":1735},"obj":"Sentence"},{"id":"T234","span":{"begin":1736,"end":1946},"obj":"Sentence"},{"id":"T235","span":{"begin":1947,"end":2086},"obj":"Sentence"},{"id":"T236","span":{"begin":2087,"end":2159},"obj":"Sentence"},{"id":"T237","span":{"begin":2160,"end":2270},"obj":"Sentence"},{"id":"T238","span":{"begin":2271,"end":2373},"obj":"Sentence"},{"id":"T239","span":{"begin":2374,"end":2462},"obj":"Sentence"},{"id":"T240","span":{"begin":2463,"end":2591},"obj":"Sentence"},{"id":"T241","span":{"begin":2592,"end":2687},"obj":"Sentence"},{"id":"T242","span":{"begin":2688,"end":2755},"obj":"Sentence"},{"id":"T243","span":{"begin":2756,"end":2997},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T162","span":{"begin":122,"end":141},"obj":"Phenotype"},{"id":"T163","span":{"begin":316,"end":327},"obj":"Phenotype"},{"id":"T164","span":{"begin":510,"end":521},"obj":"Phenotype"},{"id":"T165","span":{"begin":581,"end":594},"obj":"Phenotype"},{"id":"T166","span":{"begin":630,"end":641},"obj":"Phenotype"},{"id":"T167","span":{"begin":646,"end":655},"obj":"Phenotype"},{"id":"T168","span":{"begin":689,"end":707},"obj":"Phenotype"},{"id":"T169","span":{"begin":1008,"end":1017},"obj":"Phenotype"},{"id":"T170","span":{"begin":1037,"end":1048},"obj":"Phenotype"},{"id":"T171","span":{"begin":1053,"end":1062},"obj":"Phenotype"},{"id":"T172","span":{"begin":1393,"end":1415},"obj":"Phenotype"},{"id":"T173","span":{"begin":1609,"end":1620},"obj":"Phenotype"},{"id":"T174","span":{"begin":1680,"end":1699},"obj":"Phenotype"},{"id":"T175","span":{"begin":1701,"end":1704},"obj":"Phenotype"},{"id":"T176","span":{"begin":2592,"end":2611},"obj":"Phenotype"},{"id":"T177","span":{"begin":2688,"end":2691},"obj":"Phenotype"},{"id":"T178","span":{"begin":2794,"end":2809},"obj":"Phenotype"},{"id":"T179","span":{"begin":2925,"end":2947},"obj":"Phenotype"},{"id":"T180","span":{"begin":2949,"end":2968},"obj":"Phenotype"},{"id":"T181","span":{"begin":2970,"end":2981},"obj":"Phenotype"},{"id":"T182","span":{"begin":2987,"end":2996},"obj":"Phenotype"}],"attributes":[{"id":"A162","pred":"hp_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A163","pred":"hp_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/HP_0000093"},{"id":"A164","pred":"hp_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/HP_0000093"},{"id":"A165","pred":"hp_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/HP_0000112"},{"id":"A166","pred":"hp_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/HP_0000093"},{"id":"A167","pred":"hp_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/HP_0000790"},{"id":"A168","pred":"hp_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/HP_0000790"},{"id":"A169","pred":"hp_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/HP_0000790"},{"id":"A170","pred":"hp_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/HP_0000093"},{"id":"A171","pred":"hp_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/HP_0000790"},{"id":"A172","pred":"hp_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A173","pred":"hp_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/HP_0012592"},{"id":"A174","pred":"hp_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A175","pred":"hp_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A176","pred":"hp_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A177","pred":"hp_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A178","pred":"hp_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/HP_0000112"},{"id":"A179","pred":"hp_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A180","pred":"hp_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A181","pred":"hp_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/HP_0000093"},{"id":"A182","pred":"hp_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/HP_0000790"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}

    2_test

    {"project":"2_test","denotations":[{"id":"32450165-32247631-66451083","span":{"begin":2725,"end":2728},"obj":"32247631"}],"text":"6.3 SARS-CoV-2- kidney risk\nIt is suspected that whether the patients with predisposed kidney issues or COVID-19 induced acute kidney injury is fatal to the affected patients. In an article posted on March 19 by HospiMedica International staff writers, it was mentioned that patients affected by COVID-19 developed proteinuria estimated by the elevated levels of albumin in urine were diagnosed in the initial stages of infection. The majority of the affected members, i.e., 34% out of 59 patients, developed proteinuria where the elevated albumin levels serve as a biomarker for kidney damage, and 63% of the patients exhibited proteinuria and hematuria characterized by the presence of blood in the urine. In another study conducted on 710 patients hospitalized due to COVID-19. The impairment in the functioning of the kidney was observed in 27% of the 59 patients and 66% of the corona infected patients. In a later study conducted on COVID-19 affected patients from 710 hospitals, 26.7% exhibited only hematuria, and 44% exhibited proteinuria and hematuria. The impaired kidney function was found in 15% of the study population [98].\nAccording to an article published by Wang L and his colleagues reported that out of 116 COVID-19 positive cases from Renmin Hospital of Wuhan University, out of whom 111 didn't have any kidney issues in their history and the remaining five patients had chronic kidney disease (CDK). Also, out of the 111 patients, only 10.8% of the patients exhibited a slight increase in creatine or blood urea nitrogen levels, and 7.2% of the patients had shown a minute raise in the albuminuria levels. None of the patients out of 111 didn't exhibit any acute kidney injury (AKI) after the COVID-19 infection. The remaining five patients who were already undergoing continuous renal replacement therapy (CRRT) also didn't show any fatal effects after COVID-19 infection confirmed by diagnosing the renal indicators [99]. Out of 701 patients, 2% of the patients were found to have CKD, and the average lymphocytic number was found to be reduced than the normal. High sensitivity C-reactive protein levels were significantly increased. In patients reported with high levels of serum, creatine indicated high levels of serum lactose dehydrogenase. Among hospitalized patients, patients with high levels of serum creatine were mostly old and male sex. Also, they exhibited lower platelet and lymphocytic count and elevated leukocytic count. The patients with elevated procalcitonin also exhibited elevated levels of aspartate aminotransferase and lactate dehydrogenase. Acute kidney injury was significantly higher in those patients with high serum creatine levels. AKI eventually results in mortality [100] (represented in Table 1). Therefore, advanced identification of kidney diseases in patients affected by COVID-19 may help the clinicians to reduce the mortality rate due to comorbidities such as chronic kidney disease, acute kidney injury, proteinuria, and hematuria."}